Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dymista vs Azelastine vs Fluticasone in Chinese AR/ARC
CTR20180358Phase 3Completed
- Sponsor
- Meda
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC), sponsored by Meda. Started Mar 2018; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on CTR20180358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180358.